Skip to search formSkip to main contentSkip to account menu

NXY 059

Known as: NXY-059, NXY059 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
The most deadly form of stroke, intracerebral hemorrhage (ICH) continues to puzzle researchers and produce substantial decrements… 
2006
2006
ABSTRACT Objective: NXY-059 is a novel, free-radical trapping, neuroprotectant that reduces infarct size and preserves brain… 
2006
2006
address the lack of reliable outcome data for self-management provided by individual trials, Heneghan and colleagues used meta… 
Review
2006
Review
2006
Clinical trials with radical scavenging antioxidants have shown little or no benefit in the treatment of ischemic stroke. The… 
Review
2004
Review
2004
Free radicals play an important role in secondary processes in ischaemic brain injury. Disodium 4‐[(tert‐butylimino) methyl… 
Review
2002
Review
2002
Centaur and AstraZeneca are developing NXY-059, an alpha-phenyl-N-tert-butyl nitrone derivative, free radical trapping agent, for… 
2002
2002
Stroke is considered the third leading cause of death and the major cause of disability in the U.S. There are 2 major therapeutic… 
2000
2000
The plate reformer consisting of combustion chamber and reforming chamber, which can be integrated in the MCFC fuel cell system…